165 related articles for article (PubMed ID: 19943027)
1. Rapamycin and the transcription factor C/EBPbeta as a switch in osteoclast differentiation: implications for lytic bone diseases.
Smink JJ; Leutz A
J Mol Med (Berl); 2010 Mar; 88(3):227-33. PubMed ID: 19943027
[TBL] [Abstract][Full Text] [Related]
2. Rapamycin inhibits osteoclast formation in giant cell tumor of bone through the C/EBPβ - MafB axis.
Smink JJ; Tunn PU; Leutz A
J Mol Med (Berl); 2012 Jan; 90(1):25-30. PubMed ID: 22071989
[TBL] [Abstract][Full Text] [Related]
3. Transcription factor C/EBPbeta isoform ratio regulates osteoclastogenesis through MafB.
Smink JJ; Bégay V; Schoenmaker T; Sterneck E; de Vries TJ; Leutz A
EMBO J; 2009 Jun; 28(12):1769-81. PubMed ID: 19440205
[TBL] [Abstract][Full Text] [Related]
4. CCAAT/enhancer-binding protein β promotes receptor activator of nuclear factor-kappa-B ligand (RANKL) expression and osteoclast formation in the synovium in rheumatoid arthritis.
Tsushima H; Okazaki K; Ishihara K; Ushijima T; Iwamoto Y
Arthritis Res Ther; 2015 Feb; 17(1):31. PubMed ID: 25811130
[TBL] [Abstract][Full Text] [Related]
5. Expression and function of CCAAT/enhancer binding proteinbeta (C/EBPbeta) LAP and LIP isoforms in mouse mammary gland, tumors and cultured mammary epithelial cells.
Dearth LR; Hutt J; Sattler A; Gigliotti A; DeWille J
J Cell Biochem; 2001; 82(3):357-70. PubMed ID: 11500913
[TBL] [Abstract][Full Text] [Related]
6. Deficiency in mTORC1-controlled C/EBPβ-mRNA translation improves metabolic health in mice.
Zidek LM; Ackermann T; Hartleben G; Eichwald S; Kortman G; Kiehntopf M; Leutz A; Sonenberg N; Wang ZQ; von Maltzahn J; Müller C; Calkhoven CF
EMBO Rep; 2015 Aug; 16(8):1022-36. PubMed ID: 26113365
[TBL] [Abstract][Full Text] [Related]
7. 1,25-Dihydroxyvitamin D3 inhibits directly human osteoclastogenesis by down-regulation of the c-Fms and RANK expression.
Kim TH; Lee B; Kwon E; Choi CH; Sung IH; Kim Y; Sohn J; Ji JD
Joint Bone Spine; 2013 May; 80(3):307-14. PubMed ID: 23116709
[TBL] [Abstract][Full Text] [Related]
8. C/EBP transcription factors in human squamous cell carcinoma: selective changes in expression of isoforms correlate with the neoplastic state.
Anand S; Ebner J; Warren CB; Raam MS; Piliang M; Billings SD; Maytin EV
PLoS One; 2014; 9(11):e112073. PubMed ID: 25402211
[TBL] [Abstract][Full Text] [Related]
9. Deregulation of the endogenous C/EBPβ LIP isoform predisposes to tumorigenesis.
Bégay V; Smink JJ; Loddenkemper C; Zimmermann K; Rudolph C; Scheller M; Steinemann D; Leser U; Schlegelberger B; Stein H; Leutz A
J Mol Med (Berl); 2015 Jan; 93(1):39-49. PubMed ID: 25401168
[TBL] [Abstract][Full Text] [Related]
10. Col1a1 promoter-targeted expression of p20 CCAAT enhancer-binding protein beta (C/EBPbeta), a truncated C/EBPbeta isoform, causes osteopenia in transgenic mice.
Harrison JR; Huang YF; Wilson KA; Kelly PL; Adams DJ; Gronowicz GA; Clark SH
J Biol Chem; 2005 Mar; 280(9):8117-24. PubMed ID: 15598659
[TBL] [Abstract][Full Text] [Related]
11. CCAAT/enhancer-binding protein beta plays a regulatory role in differentiation and apoptosis of neuroblastoma cells.
Cortés-Canteli M; Pignatelli M; Santos A; Perez-Castillo A
J Biol Chem; 2002 Feb; 277(7):5460-7. PubMed ID: 11733516
[TBL] [Abstract][Full Text] [Related]
12. CCAAT/enhancer-binding protein β expressed by bone marrow mesenchymal stromal cells regulates early B-cell lymphopoiesis.
Yoshioka S; Miura Y; Yao H; Satake S; Hayashi Y; Tamura A; Hishita T; Ichinohe T; Hirai H; Takaor-Kondo A; Maekawa T
Stem Cells; 2014 Mar; 32(3):730-40. PubMed ID: 24115241
[TBL] [Abstract][Full Text] [Related]
13. Complement component 3 (C3) expression in the hippocampus after excitotoxic injury: role of C/EBPβ.
Hernandez-Encinas E; Aguilar-Morante D; Morales-Garcia JA; Gine E; Sanz-SanCristobal M; Santos A; Perez-Castillo A
J Neuroinflammation; 2016 Oct; 13(1):276. PubMed ID: 27769255
[TBL] [Abstract][Full Text] [Related]
14. Thrombopoietic effects of CCAAT/enhancer-binding protein β on the early-stage differentiation of megakaryocytes.
Song H; Liu J; Tian X; Liu D; Li J; Zhao X; Mei Z; Yan C; Han Y
Arch Biochem Biophys; 2021 May; 703():108846. PubMed ID: 33744198
[TBL] [Abstract][Full Text] [Related]
15. The transcription factor C/EBPβ orchestrates dendritic cell maturation and functionality under homeostatic and malignant conditions.
Scholz F; Grau M; Menzel L; Graband A; Zapukhlyak M; Leutz A; Janz M; Lenz G; Rehm A; Höpken UE
Proc Natl Acad Sci U S A; 2020 Oct; 117(42):26328-26339. PubMed ID: 33020261
[TBL] [Abstract][Full Text] [Related]
16. The C/EBPβ LIP isoform rescues loss of C/EBPβ function in the mouse.
Bégay V; Baumeier C; Zimmermann K; Heuser A; Leutz A
Sci Rep; 2018 May; 8(1):8417. PubMed ID: 29849099
[TBL] [Abstract][Full Text] [Related]
17. CCAAT/enhancer-binding protein beta (C/EBPβ) knockdown reduces inflammation, ER stress, and apoptosis, and promotes autophagy in oxLDL-treated RAW264.7 macrophage cells.
Zahid MDK; Rogowski M; Ponce C; Choudhury M; Moustaid-Moussa N; Rahman SM
Mol Cell Biochem; 2020 Jan; 463(1-2):211-223. PubMed ID: 31686316
[TBL] [Abstract][Full Text] [Related]
18. CCAAT/enhancer-binding protein beta promotes osteoblast differentiation by enhancing Runx2 activity with ATF4.
Tominaga H; Maeda S; Hayashi M; Takeda S; Akira S; Komiya S; Nakamura T; Akiyama H; Imamura T
Mol Biol Cell; 2008 Dec; 19(12):5373-86. PubMed ID: 18843047
[TBL] [Abstract][Full Text] [Related]
19. Helenalin Acetate, a Natural Sesquiterpene Lactone with Anti-inflammatory and Anti-cancer Activity, Disrupts the Cooperation of CCAAT Box/Enhancer-binding Protein β (C/EBPβ) and Co-activator p300.
Jakobs A; Steinmann S; Henrich SM; Schmidt TJ; Klempnauer KH
J Biol Chem; 2016 Dec; 291(50):26098-26108. PubMed ID: 27803164
[TBL] [Abstract][Full Text] [Related]
20. CCAAT/enhancer binding protein β is required for satellite cell self-renewal.
Lala-Tabbert N; AlSudais H; Marchildon F; Fu D; Wiper-Bergeron N
Skelet Muscle; 2016 Dec; 6(1):40. PubMed ID: 27923399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
